Ribosome P Antibody

Ribosomal P Antibody Test

The Ribosomal P Antibody Test, also known as the Anti-Ribosomal P Protein Antibody Test or Anti-P Antibody Test, is a specialized blood test that detects autoantibodies directed against ribosomal P proteins.

Ribosomal P proteins are components of the large ribosomal subunit and participate in cellular protein synthesis. In some people with autoimmune disease, the immune system mistakenly produces antibodies against these proteins. Anti-ribosomal P antibodies are strongly associated with systemic lupus erythematosus (SLE) and are considered highly specific but relatively insensitive markers for the disease.

Systemic lupus erythematosus is a chronic autoimmune condition that may affect the joints, skin, kidneys, blood cells, lungs, heart, nervous system and other organs. Symptoms vary widely and may include:

• Joint pain and swelling
• Persistent fatigue
• Facial or body rash
• Photosensitivity
• Mouth ulcers
• Unexplained fever
• Hair loss
• Kidney abnormalities
• Chest pain
• Headache, seizures or behavioural changes

Anti-ribosomal P antibodies have been studied particularly in relation to neuropsychiatric lupus, including psychosis, mood disorders and other neurological manifestations. Some studies have also reported associations with lupus nephritis, hepatic involvement and higher disease activity. However, these relationships are not consistent enough for the antibody to diagnose a particular organ manifestation by itself.

A positive Ribosomal P Antibody result may support an SLE diagnosis, especially in a patient with compatible symptoms and positive antinuclear antibodies. However, the result must be interpreted together with clinical examination and other investigations.

The test is usually included in an extended ANA or connective tissue disease antibody profile. Common accompanying tests include:

• Antinuclear antibody by indirect immunofluorescence
• Anti-double-stranded DNA antibodies
• Anti-Smith antibodies
• Anti-Ro/SSA and Anti-La/SSB antibodies
• Complement C3 and C4
• Complete blood count
• Urine examination and urine protein testing
• Kidney and liver function tests

Test Purpose

The Ribosomal P Antibody Test may help:

• Support the diagnosis of systemic lupus erythematosus.
• Evaluate patients with a positive ANA and lupus-like symptoms.
• Provide additional information when common lupus-specific antibodies are negative.
• Assist in assessing suspected neuropsychiatric lupus.
• Support evaluation of possible renal or hepatic lupus involvement.
• Characterize the patient’s autoimmune antibody profile.

Benefits

Anti-ribosomal P antibodies have high specificity for SLE, so a clearly positive result may provide valuable supporting evidence. However, because only a minority of patients with lupus have these antibodies, a negative result cannot rule out the disease.

Why Doctors Recommend It

Doctors may recommend this test when a patient has suspected lupus, unexplained multisystem symptoms, neuropsychiatric manifestations, abnormal liver tests, kidney involvement or an ANA result requiring further investigation.

Preparation

No fasting or special preparation is generally required.

Inform the healthcare provider about:

• Current autoimmune symptoms
• Previous ANA or lupus test results
• Kidney or liver disease
• Neurological or psychiatric symptoms
• Recent infections
• Current medications
• Immunosuppressive treatment

A venous blood sample is collected, and the separated serum is tested using an immunoassay.

Reporting Time

Typically: 3–7 working days

The reporting time may vary according to the testing method and laboratory workflow.

Who Should Take the Test?

The test may be recommended for:

• Patients with suspected systemic lupus erythematosus
• Individuals with a positive ANA result
• Patients with lupus-like symptoms and negative routine antibodies
• People with unexplained neurological or psychiatric symptoms and suspected lupus
• Patients with possible lupus nephritis
• Individuals with abnormal liver tests and suspected autoimmune disease
• Patients with joint pain, rash and photosensitivity
• People undergoing an extended connective tissue disease evaluation
• Patients referred by a rheumatologist, neurologist or nephrologist
• Anyone advised by a qualified healthcare professional